Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D02WMX
|
|||
Former ID |
DIB009823
|
|||
Drug Name |
CR-6261
|
|||
Synonyms |
Flu-mAb; H5N1 and H1N1 influenza monoclonal antibody therapy (PER.C6); Avian influenza monoclonal antibody therapy (PER.C6), Crucell; H5N1 and H1N1 influenza monoclonal antibody therapy (PER.C6), Crucell; H5N1 influenza monoclonal antibody therapy (PER.C6), Crucell
Click to Show/Hide
|
|||
Indication | Influenza A virus infection [ICD-11: 1E30] | Phase 2 | [1] | |
Company |
Crucell; celldex therapeutics; rockefeller university
|
References | Top | |||
---|---|---|---|---|
REF 1 | ClinicalTrials.gov (NCT02371668) Study in Healthy Volunteers to Evaluate the Efficacy and Safety of CR6261 in an H1N1 Influenza Healthy Human Challenge Model. U.S. National Institutes of Health. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.